Hyep Ivan

CIK 00020346681 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002034668

Recent Transactions

30 trades

Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-04$18.25/sh−2,963→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-04−2,963→ 79,784 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-04$3.79/sh+2,963→ 148,318 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$18.22/sh−13,555→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-03−7,318→ 58,144 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-03-03−6,237→ 82,747 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$3.79/sh+7,318→ 152,673 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-03-03$3.79/sh+6,237→ 158,910 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-02-02+125,000→ 125,000 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-01-22$3.79/sh+1,882→ 147,237 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2026-01-22$18.15/sh−1,882→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-01-22−1,882→ 65,462 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-24−17,795→ 98,184 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-24$3.79/sh+17,795→ 163,150 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-24$18.55/sh−17,795→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$3.79/sh+605→ 145,960 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-11-21−605→ 115,979 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-11-21$18.15/sh−605→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-09$3.79/sh+6,415→ 151,770 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-09$18.23/sh−6,415→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-09−6,415→ 116,584 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-08−5,627→ 122,999 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-08$18.21/sh−5,627→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-08$3.79/sh+5,627→ 150,982 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-07$18.22/sh−18,244→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-07$3.79/sh+18,244→ 163,599 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-07−18,244→ 128,626 total
Sale
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-06$18.17/sh−6,514→ 145,355 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Common Stock
2025-10-06$3.79/sh+6,514→ 151,869 total
Exercise/Conversion
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-10-06−6,514→ 146,870 total

Companies

Bicara Therapeutics Inc.
Chief Financial Officer
$BCAX

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov